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Abstract
Background: Fractures of the distal radius represent the most common fracture in elderly patients, and often
indicate the onset of symptomatic osteoporosis. A variety of treatment options is available, including closed
reduction and plaster casting, K-wire-stabilization, external fixation and open reduction and internal fixation (ORIF)
with volar locked plating. The latter is widely promoted by clinicians and hardware manufacturers. Closed
reduction and cast stabilization for six weeks is a simple, convenient, and ubiquitously available intervention. In
contrast, ORIF requires hospitalization, but allows for functional rehabilitation.
Given the lack of randomized controlled trials, it remains unclear whether ORIF leads to better functional outcomes
one year after injury than closed reduction and casting.
Methods/Design: ORCHID (Open reduction and internal fixation versus casting for highly comminuted intra-
articular fractures of the distal radius) is a pragmatic, randomized, multi-center, clinical trial with two parallel
treatment arms. It is planned to include 504 patients in 15 participating centers throughout Germany over a three-
year period. Patients are allocated by a central web-based randomization tool.
The primary objective is to determine differences in the Short Form 36 (SF-36) Physical Component Score (PCS)
between volar locked plating and closed reduction and casting of intraarticular, comminuted distal radius fractures
in patients > 65 years of age one year after the fracture. Secondary outcomes include differences in other SF-36
dimensions, the EuroQol-5D questionnaire, the Disability of the Arm, Shoulder, and Hand (DASH) instrument. Also,
the range of motion in the affected wrist, activities of daily living, complications (including secondary ORIF and
revision surgery), as well as serious adverse events will be assessed. Data obtained during the trial will be used for
later health-economic evaluations. The trial architecture involves a central statistical unit, an independent
monitoring institute, and a data safety monitoring board. Following approval by the institutional review boards of
all participating centers, conduct and reporting will strictly adhere to national and international rules, regulations,
and recommendations (e.g., Good Clinical Practice, data safety laws, and EQUATOR/CONSORT proposals)
Discussion: To our knowledge, ORCHID is the first multicenter RCT designed to assess quality of life and functional
outcomes following operative treatment compared to conservative treatment of complex, intra-articular fractures of
the distal radius in elderly patients. The results are expected to influence future treatment recommendations and
policies on an international level.
Trial registration: ISRCTN: ISRCTN76120052
Registration date: 31.07.2008; Randomization of first patient: 15.09.2008
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Distal radial fractures represent the most common inju-
ries in humans and make up a considerable workload in
orthopaedic and surgical departments worldwide. In
population-based investigations, incidence rates vary
from 5.7 to 124.6 per 10,000 person-years [1-21].
Together with fractures of the proximal humerus, ver-
tebral bodies and the proximal femur, fractures of the
distal radius typically mark the onset of symptomatic
osteoporosis [22-24].
Established treatment options comprise closed reduc-
tion and cast stabilization, external fixation, and open
reduction with internal plate fixation (ORIF). The first
two options may be combined with percutaneous K-
wire pinning.
According to a Cochrane Review of randomized con-
trolled trials (RCT) and later clinical investigations
[25-27], the most effective, efficient, and safe method of
treating complex intraarticular wrist fractures remains
unclear.
To date, a single RCT has compared ORIF to casting
(19 and 23 patients, respectively) [28], suggesting a
higher likelihood of excellent function with ORIF than
with closed reduction (risk ratio [RR] 0.69, 95% confi-
dence interval [CI] 0.48 - 1.00). The same trial also
compared ORIF to external fixation (19 and 18
patients), without any difference in the rates of excellent
function (RR 0.95, 95% CI 0.59 - 1.52). Two trials in
2004 and 2005 suggest better functional outcomes with
external fixation compared to internal fixation with dor-
sal Pi-plates [29-31].
In recent years, angle-stable, volar locking plates
have been propagated and enthusiastically used for
surgical fixation of distal radial fractures, especially in
the osteoporotic bone. The underlying biomechanical
principle of angle-stable locked plating is that uni-cor-
tical, threaded screws fixed in the screw hole of the
plate ("internal fixator”) reduce shear forces, thereby
preventing loosening of the surgical construct. How-
ever the available clinical evidence in favor of this
principle is limited to case series of moderate to poor
quality [32-38].
The currently largest reported series of 114 patients
also signals high complication rates with volar locking
plate fixation of complex wrist fractures. Although func-
tional outcomes after one year were reasonable, 31
patients (27%, 95% CI 19 - 36%) faced complications,
mainly tendon irritation, carpal tunnel syndrome, and
complex regional pain syndrome (CRPS) [39].
Regardless of these critical reports, volar locked plating
has emerged as the surgical standard of care for mana-
ging distal radial fractures in Europe and the US [40].
Study Rationale
Closed reduction and plaster casting is an ubiquitous,
simple, safe, and cost-effective intervention to treat dis-
tal radial fractures. Casting may be applied in an outpa-
tient setting but causes the discomfort of four to six
weeks of immobilization of the wrist. In contrast, ORIF
needs a hospital environment, well equipped operating
rooms, and costly surgical material, but allows for early
mobilization without cast immobilization.
Comminuted intraarticular wrist fractures (type 23
C1, C2, C3 according to the common classification
rules of the AO Foundation [AO/ASIF] and the Ortho-
paedic Trauma Association [OTA]) destroy cartilage
layers and compromise joint integrity (Figure 1). Biolo-
gical fracture treatment aims at restoring the axis and
length of the injured bone, reconstructing the articular
surface, and achieving a stable construct that allows
for early mobilization and weight bearing. However,
excessive reconstruction with technically demanding
and time consuming fixation of multiple small frag-
ments may produce more good than harm, especially
in the osteoporotic bone, osteoarthritis of the radio-
carpal and adjacent joints, and poor skin and soft tis-
sue conditions.
Thus, the obvious biomechanical advantages with
internal fixation (anatomic reposition and stable fixa-
tion) must be balanced against its potential biological
Figure 1 AO/ASIF-classification. AO/ASIF-classification of intraarticular distal radius fractures (C1,C2,C3).
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compound).
Given the high costs of this surgical intervention and
taking into account its so far unproven benefits for
elderly patients, there is an urgent need for a large,
multi-center RCT comparing operative with non-opera-
tive treatment. This trial should clarify whether the
anticipated benefits with ORIF hold against its invasive-
ness, potential complications, and costs.
Primary Hypothesis
Because of previous studies and international trends in
health services research, the investigators consider the
Short Form 36 (SF-36) Physical Component Score (PCS)
as the key outcome of this trial. They assume that,
based on data from other studies, a difference of 8
points (on a scale of 50) with a pooled standard devia-
tion (SD) of 3 (leading to a standardized mean differ-
ence of 8/3 = 2.67) between the experimental and the
control intervention is of both clinical and health-politi-
cal interest. As there are still no generally accepted
‘minimum clinically important differences’ (MCID) of
the SF36-PCS in patients with fractures of the long
bones, the predefined MCID was mainly based on the
widely used SEM criterion [41]
The primary hypothesis is that, after a follow-up of one
year, there is a clinically relevant standardized mean
difference of 2.67 points in the SF-36-PCS between surgi-
cal and non-surgical treatment of intra-articular frac-
tures of the distal radius in elderly patients.
Methods And Design
Design
The ORCHID (Open Reduction and internal fixation
versus Cast immobilization for Highly comminuted,
Intra-articular fractures of the Distal radius) trial is a
pragmatic, multi-center RCT that aims at evaluating dif-
ferences in patient-centered outcomes between two
major options (i.e., volar locked plating versus closed
reduction and cast stabilization) for treating wrist frac-
tures in an elderly population. 600 patients will be
recruited at 15 hospitals of various levels of care and
associated private practices throughout Germany. It is
expected that 150 patients are recruited during the first
year after the initiation of all centers, followed by
recruitment of 300 and 150 patients in the subsequent
years.
Eligibility criteria
M e na n dw o m e na g e d6 5y e a r so ro l d e rw i t ha ni s o -
lated, unilateral, closed, comminuted, intra-articular
fracture of the distal radius (AO/OTA 23 C1, C2, C3)
according to the judgment of the surgeon on call are
enrolled onto the trial.
To avoid misclassification of exposure, all radiographs
will be evaluated centrally and independently by an
orthopaedic surgeon and a radiologist. In case of dis-
agreement there will be a consensus evaluation.
Only patients with a maximum interval of one week
between injury and intervention must be included. No
specific surgical pre-treatment (i.e., K-wiring, external
fixation) is allowed. Patients must be able to understand
the meaning of the trial and its consequences. Written
informed consent or verbal agreement in presence of a
witness in case of a fracture of the dominant hand and
inability to write is mandatory for trial inclusion.
Patients will be excluded if the responsible surgeon
requests surgical treatment, especially in case of open
fractures or other situations in which the principle of
therapeutic uncertainty (equipoise) is violated.
Also, patients with a high risk of anaesthesiology pro-
blems (i.e., ASA risk score > 3), acute infection, extreme
obesity (i.e., BMI > 35 kg/m²), mental illness or low
expected compliance will be excluded from trial partici-
pation. If patients issue a certain treatment preference,
they will be excluded as well.
Randomization
After having agreed with trial participation, patients will
be randomized by the responsible surgeon to one of the
treatment arms, using a web-based randomization tool
(http://www.randomizer.at). Randomization is performed
by blocks with stratification for participating centers.
Interventions
Patients must be included only if there was no specific
(i.e., physician-performed or -prescribed) pretreatment
within one week after a traumatic exposure to the wrist.
All fractures will initially be reduced under image-
intensifier control, followed by plaster cast stabilization
(Figure 2 and 3). The intervention is performed by the
surgeon on charge with proven expertise in reduction
and casting maneuvers. Centers may follow their pre-
ferred reduction and casting techniques and locally
established interventions for pain management (i.e., frac-
ture block or intravenous pain medication).
Non-operative treatment
If randomized to non-operative care, cast treatment will
be continued for six weeks. Once swelling has
decreased, the splint cast is converted into a closed cast
(hard plaster or light cast). Patients in the non-operative
arm are usually treated in an ambulatory setting.
Operative treatment
If randomized to operative treatment, patients will be
admitted to the hospital and operated on as early as
possible, depending on local tissue conditions, hema-
toma and swelling and suitability of the patient for
anaesthesia.
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using angle stable locking plates (Figure 4, 5 and 6). The
protocol does not mandate certain hardware. ORIF is
performed under plexus or general anesthesia and
fluoroscopic guidance. All surgeons performing the
operation have proven expertise with the procedure and
are familiar with the used implants. Post-operative cast
stabilization of the wrist may not exceed two weeks.
Outcome measures
Primary outcome
T h ep r i m a r yo b j e c t i v eo fO R C H I Di st oc o m p a r e
patient-reported outcomes like function, independence
and health-related quality of life, measured with the
Short Form 36 (SF-36) Physical Component Score
(PCS), after operative and non-operative treatment of
comminuted wrist fractures rather than surrogate mea-
sures (i.e., radiographic healing).
The Short Form 36 (SF-36) is the most widely used
generic health assessment questionnaire worldwide. Its
validity and suitability to describe wellbeing in a broad
range of clinical conditions from a patient’s point of
view has been studied extensively [41-44].
Secondary outcomes
Another quick and validated tool is the EuroQol-5D
(EQ-5D). Health utility measures can easily be derived
from this instrument, allowing for later health-economic
analyses. With the EuroQol-5D the outcomes of the two
treatment arms can be compared and health-related
quality of life can be measured.
In addition to generic forms, the 30-item, self-reported
Disability of the Arm, Shoulder and Hand Score
(DASH) questionnaire will be employed as a disease-
specific outcome measure.
The DASH was selected as the preferred specific out-
come tool because of the longer experience gained with
this instrument in Germany. Cross-cultural validation
started as early as 2003 [45]. DASH is the recommended
tool for outcome assessment in the national clinical
guideline for managing fractures of the distal radius
http://www.uni-duesseldorf.de/AWMF/ll/012-015.htm
and shows comparable psychometric properties to the
Patient-Rated Wrist Evaluation PRWE in evaluating
recovery after a distal radius fracture [46].
The SF-36, the DASH and the EuroQol-5D are
assessed as patient completed questionnaires with
Figure 2 Closed reduction and casting.C l o s e dr e d u c t i o na n d
casting of an intraarticular distal radius fracture in the finger-trap
traction technique with a light cast.
Figure 3 Post-reduction radiograph of the wrist. Mild shortening
of radial length in the anteroposterior view after casting.
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or at the outpatient visit.
Wrist function in terms of range of motion (ROM) will
be measured using a goniometer. Finally, we will address
the patients’ independence and ability to cope with every-
day activities, nursing home admissions and the need for
assistance in activities of daily living, and mortality. Com-
plications (e.g., loss of reduction, hardware failure and
misplacement, wound healing problems, infections, revi-
sions, neurologic impairment, pressure ulcera and others)
as well as serious adverse events (SAE) will be recorded
throughout the study, and reg u l a r l ye v a l u a t e db yaD a t a
Safety Monitoring Board (DSMB).
Evaluation and follow-up
Clinical evaluation and trial documentation consists of
six visits: baseline (V1), intervention (V2) and four post-
operative follow-up examinations ending with V6 after
12 months (see summary in Table 1).
V1 - baseline examination and randomization
After radiological verification of the suitable fracture
type, eligibility criteria are checked at the baseline and
trial entry visit. The trial aims and procedures are
explained to patients by the responsible local investiga-
tors using a leaflet. Informed consent is obtained, and
the trial participant is centrally randomized to operative
or conservative management. Baseline demographics,
Figure 4 Intraarticular distal radius fracture. Anteroposterior
radiograph of an intraarticular distal radius fracture type C1-AO/ASIF.
Figure 5 Operative treatment. Postoperative radiograph shows
restoration of radial length.
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tures, fear of falling and the diagnosis of osteoporosis
are recorded at this time. Falls, fracture falls, and fear of
falling are variables associated with a generally poorer
prognosis including higher mortality, and predictors of
future falls in frail elderly patients [47-50].
V2 - treatment
This visit is intended to describe the individual proce-
dures and procedure-related complications (see inter-
ventions). In both treatment arms the intervention is
performed by the responsible surgeon.
V3 - one to six days post intervention
Radiographs are taken to evaluate the quality of reduc-
tion (radial inclination, palmar inclination, ulnar
l e n g t h ,a sw e l la st h ea p p r o p riate positioning of hard-
ware in the surgical trial arm). To gain information on
self-rated independence and wellbeing prior to the
fracture event, the EuroQol-5D will be queried at this
time. The investigators are aware of the limitations of
retrospective assessment of quality of life but consider
a baseline rating important for longitudinal compari-
sons. To avoid bias caused by discomfort and pain in
the acute fracture setting, baseline information is gath-
ered after fracture stabilization and sufficient pain
control.
V4 - two weeks (± 3 days) post intervention
The two-week control is crucial for deciding whether
conservative treatment is likely to lead to bony consoli-
dation in an acceptable anatomical position, or whether
conversion to surgical fixation is deemed necessary.
Between V2 and V4, another attempt of close reduction
and casting is allowed. The duration of hospital stay,
complications and SAE, and concomitant (pain) medica-
tion are recorded.
V5 - three months (± 7 days) post intervention
Patients are seen in an outpatient visit and are examined
by the responsible surgeon. Wrist radiographs are
obtained after three months, and will be scrutinized for
healing and alignment. Apart from other local complica-
tions, signs of chronic regional pain syndrome (CRPS I)
Figure 6 Operative treatment. Lateral wrist radiograph shows
restoration of palmar inclination.
Table 1 Summary of trial-specific interventions and documentation
V1 V2 V3 V4 V5 V6
Baseline Treatment 1 d post-intervention 2 w post-intervention 3 mo post-intervention 12 mo final F/U
Assessment LI LI, RA LI, RA, SR LI, RA, SR LI, RA, SR LI, RA, SR
Entry criteria X
Randomization X
Radiographs X X X X X optional
SF-36 XX
EQ-5D X X X
DASH XX
Wrist ROM XX
Complications X X X X X
SAE X X X X X
LI = local investigator, RA = research assistant/study nurse, SR = patient self report.
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are documented.
The SF-36, the EQ-5D, the DASH and wrist range of
motion will be assessed by a trained study nurse to limit
bias.
V6 - twelve months (± 1 month) post intervention, final
follow-up
Patients are invited for an outpatient visit and are exam-
ined by the responsible surgeon for the final follow up.
Radiographs of the wrist are obtained if deemed neces-
sary by the surgeon. Further outcomes collected by a
study nurse comprise the the SF-36, the EQ-5D, the
DASH, and wrist ROM as well as complications and SAE.
If patients are not able to visit the study center, a
home visit is done by a trained study nurse, assessing all
scores and performing the physcial examination.
Figure 7 shows the frequency and scope of the study
visits.
Blinding
Options for blinding outcome-assessors were discussed
extensively by the members of the trial steering committee
Figure 7 CONSORT flowchart diagram. Frequency and scope of study visits.
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consented to no blinding, considering that blinding of a
non-operative treatment (casting) against a surgical inter-
vention is rather complex and would neccessitate time,
effort and expenditures. The SF-36 will be assessed by an
independent examiner after three months and one year,
limiting the degree of observer bias for this endpoint.
Statistical analysis
Sample size and power calculation
The sample size is based on the primary outcome vari-
able and the primary analysis. In the German branch of
the International Quality of Life Assessment (IQOLA)
Project, the linear T-score transformed, US factor
weighted PCS of the SF-36 score from 2525 subjects
showed a mean of 50.6 with a standard deviation of 9.8
[43]. Standard deviations of about 10 have been
observed in studies of elbow fractures as well [51].
Different assumptions can be found about the mini-
mally clinically relevant differences (MCRD) in SF-36
scales. The ORCHID investigators consider an MRCD
of 8 points with a standard deviation of 30 clinically
relevant. For the PCS scale with a standardized mean of
50 and a standard deviation of 10, this results in a
MCRD of 8/3 = 2.67 points. This is close to Walters
MCRD proposal of a clinically relevant difference of 2.5
[52]. According to another statistical approach, the
MCRD calculates to 2.83, accounting for a reported
reliability coefficient of 0.92. Using a more conservative
MCRD of 2.5 with a standard deviation of 10, 2 × 252 =
504 patients are needed to detect this difference with a
power of 80% and a two-sided alpha of 5% with a test
for means in independent samples.
The trial should also have sufficient power for the
sensitivity analyses with the per-protocol-population.
Incorporating 15% drop-outs (that is, deceased patients
and losses to follow-up), a total sample size of n = 600
patients is needed.
Data-analysis
The confirmatory analysis will be performed on the
basis of an intention-to-treat (ITT) population and with
respect to ITT principles. In this protocol, we adhere to
the original meaning of the intent-to-treat analysis,
namely analyzing patients according to their random
assignment, regardless of the treatment actually applied.
Additional analysis will be conducted on the per-pro-
tocol population (e.g., patients assigned to closed reduc-
tion but crossing over to ORIF).
Descriptive statistics for continuous variables and
scores include the number of non-missing observations,
mean, standard deviation, median, minimum and maxi-
mum, performed for the different subgroups as well as
the treatment groups and overall. The description of
categorical variables (ordinal or nominal) includes the
number and percentage of patients belonging to the
relevant categories in the trial group as well as to each
treatment group.
The primary efficacy endpoint is the Physical Compo-
nent Score (PCS) of the SF-36, ascertained 12 months
after randomization. The underlying two sided null-
hypothesis is that both interventions lead to similar
means of the SF36-PCS in both intervention groups 12
months after randomization.
[1] H0: μ1-μ2=0
The alternative hypothesis is that any intervention
performs better than the other:
[2] HA: μ1-μ2 ≠ 0
A confirmatory intention to treat analysis (2-sided
test), including all patients as randomized, will be per-
formed on the mean differences in the SF36-PCS values
between the two treatment groups. Analysis of covar-
iance (ANCOVA) techniques will be used to detect pos-
sible treatment effects, with trial center, fracture type
and gender as factors and age as continuous covariates.
Secondary endpoints will be analyzed in an explora-
tory fashion, using appropriate statistical methods based
on the underlying distribution of the data. Sensitivity
analyses will be conducted including different popula-
tions (per-protocol population, intention-to-treat popu-
lation, with values of drop-outs set to worst scores),
statistical methods (nonparametric methods, mixed
effects analysis [53]), and covariates.
Graphical methods including scatter plots and box-
plots will be used to visualize possible correlations
between continuous variables and differences between
intervention groups. We will explicitly state numerators
and denominators in case of incomplete data, and
attempts will be made for multiple imputation where
sound and necessary. All analyses will employ SAS Ver-
sion 9.1.
Patient drop-out and protocol violations
Patients lost to follow-up or who leave the study early
are documented, including the reason for drop-out.
Deviations from the protocol-driven surgical technique,
e.g. dorsal plating or K-wire pinning will be recorded.
Patients who cross-over from one treatment arm to
another, e.g., those having been assigned to casting but
undergoing secondary ORIF due to unacceptable loss of
reduction, will be evaluated according to ITT.
Safety
All adverse events (AE) during the study period will be
documented. Rates of complication and serious adverse
events (SAE) are part of the secondary endpoint analysis
and will be closely monitored. Expected complications
in both intervention groups include loss of reduction,
hardware displacement, hardware failure, sensomotoric
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blems, superficial and deep infection, skin pressure
ulcera, malunion, nonunion, revision surgery, and CRPS.
The severity of complications is categorized into
minor and major and their causality to the trial inter-
vention is evaluated. Complications leading to surgical
revision, clinically important morbidity or mortality are
classified as SAE. All SAE occurring during the study
period (regardless of their association with the trial
intervention) are graded according to their magnitude
and their outcomes.
A Data Safety and Monitoring Board (DSMB) was
constituted consisting of independent trauma surgeons
and a statistician. Annually, the board members are
furnished with safety data (frequency and distribution of
SAE) and will provide recommendations to the principal
investigator and the steering committee to decide about
continuation or modification of the trial.
Trial documentation and data collection
Paper based case report forms (CRF) will be used for
documentation. Entries will be transferred into an elec-
tronic format by trained personnel, using a double-data-
entry strategy. All source documents are available in
electronic and paper format.
All complications and SAE are documented on a spe-
cial documentation sheet. SAE will be reported to the
principal investigator as soon as possible by fax, at the
latest within five days.
Monitoring
To ensure patients’ safety and integrity of clinical data,
e.g., correct informed consent procedure and primary
endpoint evaluation in adherence to the study protocol,
continuous clinical monitoring procedures are set in
place. Clinical monitors from the Coordination Centre
for Clinical Trials (KKS), Heidelberg, Germany, will
introduce all sites to study procedures and documenta-
tion before beginning of the trial. Onsite monitoring
during the study will be done by personal visits accord-
ing to the standard operating procedures of the KKS.
The monitors review amongst others the entries into
case report forms on the basis of source documents.
Therefore, each investigator must allow monitors full
access to all essential documents, and must provide
necessary support to the monitors. In addition to regu-
lar site visits, continuous support is guaranteed through
email- and phone communication between monitor and
trial site.
Patient data safety
Throughout the trial, subjects will be identified solely by
an individual identification code. Case report forms will
be stored in accordance with local data protection laws
and will be handled with strictest confidence. The
appropriate regulations of local data legislation will be
fulfilled in their entirety. Authorized persons only (e.g.,
clinical monitors) will have access to personal data. Dur-
ing onsite visits, clinical monitors will inspect subject-
related data to ensure adherence to data protection laws
and correctness and completeness of data.
Ethical issues
The procedures set out in the trial protocol, pertaining
to the conduct, evaluation, and documentation of this
trial, are designed to ensure that all persons involved in
the trial abide by Good Clinical Practice (GCP) [54] and
the ethical principles described in the Declaration of
Helsinki [55]. The trial is carried out in compliance with
local legal and regulatory requirements, although
German Drug Law and Medical Device Law are not
applicable.
Before the first subject was enrolled, all ethical and
legal requirements were met by inclusive unreserved
approval by institutional review boards (IRB). The final
study protocol and the final version of the written
informed consent form were approved by the ethics
committee of the University of Ulm, who is responsible
for the Principal Investigator. The critical assessments of
risks and benefits have been performed by medical
experts in advance.
Each site’s principal investigator ensures that all per-
sons assisting with the trial are adequately informed
about the protocol, the trial treatments, and their trial-
related duties and functions.
Before being enrolled onto the clinical trial, each sub-
ject must consent to participate after nature, scope, and
possible consequences of the clinical trial have been
explained to him or her in an understandable oral and
written form. The subject must give consent in writing
or orally in presence of an independent witness before
randomization.
Results of study will be published according to the
recommendations issued by the Enhancing Quality and
Transparency of Health Research (EQUATOR) [56] net-
work, specifically the most recent version of the Conso-
lidated Standards of Reporting Trials (CONSORT)
statement.
Discussion
Fractures of the distal radius are an emerging public
health concern. With the reversal of the aging pyramid,
an epidemic of these functional important injuries to
the wrist and hand are projected, that need to be mana-
ged at institutions of different levels of care in the
industrial countries.
The invention of locking plates that show excellent
stability even in the osteoporotic bone increased the
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been managed conservatively in the past. It is, how-
ever, unclear whether the known biomechanical advan-
tages translate into better clinical outcomes. In the US,
it could recently been shown that the choice of treat-
ment depends on age, the place of living, insurance
and other issues unrelated to fracture severity and
grading [57].
Current evidence, specifically reliable information
from RCTs, is insufficient to counsel patients and their
relatives with regard to the most convenient, efficient,
and safe method to restore function, activity, grip
strength and so on after a complex distal radial fracture.
As far as we are aware, the ORCHID trial is the first
multicenter RCT that aims at generating conclusive evi-
dence for clinical practice guidelines and health-care
policies on the most appropriate way of treating intraar-
ticular distal radius fractures.
Research plan
Start date: September 2008.
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